{
    "organizations": [],
    "uuid": "779dd69955ec2eef30ba6754f2a27b05c0dc995f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-proteostasis-receives-fda-fast-tra/brief-proteostasis-receives-fda-fast-track-designation-for-triple-combination-program-in-patients-with-cystic-fibrosis-idUSASC09UUD",
    "ord_in_thread": 0,
    "title": "BRIEF-Proteostasis Receives FDA Fast Track Designation For Triple Combination Program In Patients With Cystic Fibrosis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - Proteostasis Therapeutics Inc:\n* PROTEOSTASIS THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR TRIPLE COMBINATION PROGRAM IN PATIENTS WITH CYSTIC FIBROSIS\n* ‍FDA GRANTED FAST TRACK DESIGNATION FOR CO’S TRIPLE COMBINATION PROGRAM FOR TREATMENT OF CYSTIC FIBROSIS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-04T18:10:00.000+03:00",
    "crawled": "2018-04-04T13:21:48.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "proteostasis",
        "therapeutic",
        "inc",
        "proteostasis",
        "therapeutic",
        "receives",
        "fda",
        "fast",
        "track",
        "designation",
        "triple",
        "combination",
        "program",
        "patient",
        "cystic",
        "fibrosis",
        "granted",
        "fast",
        "track",
        "designation",
        "co",
        "triple",
        "combination",
        "program",
        "treatment",
        "cystic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}